BIG MACS Diet for Colon Cancer
Trial Summary
What is the purpose of this trial?
The long-term study objective is to develop optimized nutritional therapies for surgery and test them in clinical practice. This pilot study will test a microbiome-optimization diet in colorectal cancer surgery patients. The study hypothesizes that the Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet will provide participants with increased microbiota accessible carbohydrates (MACs) to support the microbiome and improve outcomes.
Research Team
Cyrus Jahansouz, MD
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for English-speaking adults aged 25-70 with a primary diagnosis of colon cancer stages 1-3, who can consent and follow the study protocol. Excluded are those with significant health issues like anemia or liver problems, BMI <20 or >40, psychiatric conditions affecting adherence, history of substance dependency within five years, certain surgeries or diseases (like IBD), and pregnant/nursing individuals.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-surgery Diet
Participants follow either the standard diet or the BIG MACS Diet with one protein shake per day for 4 weeks prior to surgery
Post-surgery Diet
Participants continue the BIG MACS Diet for an additional four weeks after surgery, with solid food reintroduction as early as tolerated
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of bowel movements, muscle mass, and microbiome changes
Treatment Details
Interventions
- BIG MACS Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor